HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Abbondanzo, Susan J ^a   Chang, Sulie L ^a  

^a SETON HALL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; GENOTYPE; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MALE; MONOCYTE; NEUTROPHIL; NONHUMAN; RAT; TRANSGENIC RAT; ANIMAL; BLOOD; FISCHER 344 RAT; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LYMPH NODE; METABOLISM; PATHOLOGY; PHENOTYPE; SPLEEN; T LYMPHOCYTE; VIROLOGY;

AGING; ANIMALS; CHEMOKINES; HIV INFECTIONS; HIV-1; LIPOPOLYSACCHARIDES; LYMPH NODES; MALE; PHENOTYPE; RATS, INBRED F344; RATS, TRANSGENIC; SPLEEN; T-LYMPHOCYTES;

EID: 84940271748     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105256     Document Type: Article

References (53)

1. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, et al. (2012) HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 60 Suppl 1: S1-18.
2. Mills EJ, Barnighausen T, Negin J (2012) HIV and aging-preparing for the challenges ahead. N Engl J Med 366: 1270-1273.
3. (2012) Summary report from the Human Immunodeficiency Virus and Aging Consensus Project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virus. J Am Geriatr Soc 60: 974-979.
4. Nath A (2012) HIV and aging. J Neurovirol 18: 245-246.
5. (2012) Health Protection Agency. HIV in the United Kingdom. 2012 Report. London: Colindale.
6. Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, et al. (2007) End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. Aids 21: 2435-2443. (Pubitemid 350145175)
7. Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, et al. (2009) HIV infection and the risk of cancers with and without a known infectious cause. Aids 23: 2337-2345.
8. Valcour V, Sithinamsuwan P, Letendre S, Ances B (2011) Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep 8: 54-61.
9. Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, et al. (2008) Evolution of HIV dementia with HIV infection. Int Rev Psychiatry 20: 25-31. (Pubitemid 351196197)
10. Freiberg MS, Chang CC, Skanderson M, McGinnis K, Kuller LH, et al. (2011) The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C. Circ Cardiovasc Qual Outcomes 4: 425-432.
11. Womack JA, Goulet JL, Gibert C, Brandt C, Chang CC, et al. (2011) Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One 6: e17217.
12. Sulkowski MS, Thomas DL (2003) Hepatitis C in the HIV-Infected Person. Ann Intern Med 138: 197-207. (Pubitemid 36231625)
13. Ropolo A, Moron VG, Maletto B, Pistoresi-Palencia MC (2001) Diminished percentage of antigen bearing cells in the lymph nodes of immune aged rats. Exp Gerontol 36: 519-535. (Pubitemid 32201507)
14. Pahlavani MA, Vargas DA (2001) Aging but not dietary restriction alters the activation-induced apoptosis in rat T cells. FEBS Lett 491: 114-118. (Pubitemid 32172013)
15. Dawson HD, Ross AC (1999) Chronic marginal vitamin A status affects the distribution and function of T cells and natural T cells in aging Lewis rats. J Nutr 129: 1782-1790. (Pubitemid 29468589)
16. Schmucker DL, Owen TM, Issekutz TB, Gonzales L, Wang RK (2002) Expression of lymphocyte homing receptors alpha4beta7 and MAdCAM-l in young and old rats. Exp Gerontol 37: 1089-1095.
17. Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr, et al. (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 98: 9271-9276. (Pubitemid 32743906)
18. Reid W, Abdelwahab S, Sadowska M, Huso D, Neal A, et al. (2004) HIV-1 transgenic rats develop T cell abnormalities. Virology 321: 111-119. (Pubitemid 38368108)
19. Joshi PC, Raynor R, Fan X, Guidot DM (2008) HIV-1-transgene expression in rats decreases alveolar macrophage zinc levels and phagocytosis. Am J Respir Cell Mol Biol 39: 218-226.
20. Chang SL, Beltran JA, Swarup S (2007) Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model. J Virol 81: 8406-8411. (Pubitemid 47242814)
21. Peng J, Vigorito M, Liu X, Zhou D, Wu X, et al. (2010) The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol 218: 94-101.
22. Homji NF, Vigorito M, Chang SL (2012) Morphine-induced conditioned place preference and associated behavioural plasticity in HIV-1 transgenic rats. Int J Clin Exp Med 5: 105-123.
23. Chang SL, Connaghan KP (2012) Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins. J Neuroimmune Pharmacol 7: 332-340.
24. Yadav A, Pati S, Nyugen A, Barabitskaja O, Mondal P, et al. (2006) HIV-1 transgenic rat CD4+ T cells develop decreased CD28 responsiveness and suboptimal Lck tyrosine dephosphorylation following activation. Virology 353: 357-365. (Pubitemid 44419416)
25. Zhou X, Luo YC, Ji WJ, Zhang L, Dong Y, et al. (2013) Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated voltage gated sodium channel inhibitor ameliorates myocardial ischemia/reperfusion injury in rats. PLoS One 8: e74390.
26. Sengupta P (2013) The Laboratory Rat: Relating Its Age With Human's. Int J Prev Med 4: 624-630.
27. Homji NF, Mao X, Langsdorf EF, Chang SL (2012) Endotoxin-induced cytokine and chemokine expression in the HIV-1 transgenic rat. J Neuroinflammation 9: 3.
28. Chen R, Zhou H, Beltran J, Malellari L, Chang SL (2005) Differential expression of cytokines in the brain and serum during endotoxin tolerance. J Neuroimmunol 163: 53-72. (Pubitemid 40692949)
29. Aberg JA (2011) Aging, inflammation, and HIV infection. Top Antivir Med 20: 101-105.
30. Barrett L, Fowke KR, Grant MD (2012) Cytomegalovirus, aging, and HIV: a perfect storm. AIDS Rev 14: 159-167.
31. Cavanagh MM, Weyand CM, Goronzy JJ (2012) Chronic inflammation and aging: DNA damage tips the balance. Curr Opin Immunol 24: 488-493.
32. Kogut I, Scholz JL, Cancro MP, Cambier JC (2012) B cell maintenance and function in aging. Semin Immunol 24: 342-349.
33. Rymkiewicz PD, Heng YX, Vasudev A, Larbi A (2012) The immune system in the aging human. Immunol Res 53: 235-250.
34. Goronzy JJ, Weyand CM (2012) Immune aging and autoimmunity. Cell Mol Life Sci 69: 1615-1623.
35. Strauss-Ayali D, Conrad SM, Mosser DM (2007) Monocyte subpopulations and their differentiation patterns during infection. J Leukoc Biol 82: 244-252. (Pubitemid 47230633)
36. Grau V, Scriba A, Stehling O, Steiniger B (2000) Monocytes in the rat. Immunobiology 202: 94-103. (Pubitemid 30323620)
37. Tacke F, Randolph GJ (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211: 609-618.
38. Wong KL, Tai JJ, Wong WC, Han H, Sem X, et al. (2011) Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118: e16-31.
39. Schletter J, Heine H, Ulmer AJ, Rietschel ET (1995) Molecular mechanisms of endotoxin activity. Arch Microbiol 164: 383-389. (Pubitemid 26018509)
40. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, et al. (2003) Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100: 171-194. (Pubitemid 37377912)
41. Biswas SK, Lopez-Collazo E (2009) Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 30: 475-487.
42. Lester RT, Yao XD, Ball TB, McKinnon LR, Omange WR, et al. (2009) HIV-1 RNA dysregulates the natural TLR response to subclinical endotoxemia in Kenyan female sex-workers. PLoS One 4: e5644.
43. Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, et al. (2013) Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 14: 877-882.
44. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, et al. (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908: 244-254. (Pubitemid 30462008)
45. Wolf J, Weinberger B, Arnold CR, Maier AB, Westendorp RG, et al. (2012) The effect of chronological age on the inflammatory response of human fibroblasts. Exp Gerontol 47: 749-753.
46. Nixon DE, Landay AL (2010) Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS 5: 498-503.
47. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, et al. (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128: 92-105. (Pubitemid 46073065)
48. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, et al. (2007) Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 128: 83-91. (Pubitemid 46073064)
49. Smith RL, de Boer R, Brul S, Budovskaya Y, van Spek H (2013) Premature and accelerated aging: HIV or HAART? Front Genet 3: 328.
50. Manfredi R (2004) Impact of HIV infection and antiretroviral therapy in the older patient. Expert Rev Anti Infect Ther 2: 821-824.
51. Gebo KA (2006) HIV and aging: implications for patient management. Drugs Aging 23: 897-913.
52. Manfredi R, Calza L (2004) [HIV infection and AIDS in advanced age. Epidemiological and clinical issues, and therapeutic and management problems]. Infez Med 12: 152-173.
53. van Maanen M, Sutton RE (2003) Rodent models for HIV-1 infection and disease. Curr HIV Res 1: 121-130.